We’re pleased to announce, with funding from Janssen Pharmaceutical Companies of Johnson & Johnson, the opportunity for grant support through the iFORWARD: Equipping Organizations in the South through Technology to End the HIV Epidemic.
iFORWARD recognizes the barriers that Southern organizations face in accessing appropriate technology to carry out their services and achieve their mission. This initiative aims to reduce these disparities by directing funds to and building the capacity of grassroots organizations in the South to:
- Improve community access to health information.
- Enhance organizational communication systems.
- Help to maintain a sense of client social and emotional support.
- Establish and maintain a virtual community.
- Extend organizations' geographical reach.
- Reduce HIV-related stigma.
- Project-specific grants to support a distinct project with clear goals, objectives, activities and measurable outcomes. Project-specific grants aligned with iFORWARD will support projects such as:
- Digital campaigns that promote linkage to HIV prevention services, HIV care and/or treatment as prevention.
- Digital campaigns that address barriers to care.
- Digital campaigns and/or hybrid events on addressing social and structural determinants of health.
- Creation of digital health literacy materials.
- Digital and hybrid advocacy events.
- Digital and hybrid workshops/events with high-impact populations.
- General operating grants that provide financial resources to an organization in support of its mission and overall activities, including operating expenses and overhead, rather than providing support for specific projects or programs. General operating requests aligned with iFORWARD will support activities such as:
- Staffing support for social media, mass media or content creation.
- Building infrastructure for Wi-Fi.
- Expansion of telehealth services, including live video conferencing, mobile health (mHealth) apps, "store and forward" electronic transmission, remote patient observations and teletherapy, telemedicine, and telepharmacy.
- Subscriptions to Zoom or other teleconferencing platforms.
- Purchase of infrastructure building tools such as hotspots.

